Ovarian Neoplasms

Top drugs studied for this disease

EMA withdrawal · 2009-12-31
EMA Withdrawn: Evotopin (topotecan) — Beecham Group plc
EMA withdrawal of Evotopin (topotecan) from the market for ovarian neoplasms.
CLINICAL_TRIALS trial_result · 2008-01-25
Clinical Trial Update: Acupuncture for Women's Health Conditions [Phase 1]
Phase 1 clinical trial update on acupuncture for women's health conditions has completed the study.